Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Meyer M Samama

Showing results (11-20 of 26) with videos related to

Pageof 3
Sort By:
Thrombosis Research|September 3, 2010
Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: a randomised controlled trial in healthy elderly adultsMeyer M Samama, Satoshi Kunitada, Andŗe Oursin, et al.
Thrombosis and Haemostasis|February 26, 2004
Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole bloodGrigoris T Gerotziafas, François Depasse, Tahar Chakroun, et al.
Journal of Cardiovascular Pharmacology|April 26, 2013
The effects of the antiplatelet agents, aspirin and naproxen, on pharmacokinetics and pharmacodynamics of the anticoagulant edoxaban, a direct factor Xa inhibitorJeanne Mendell, Frank Lee, Shuquan Chen, et al.
Thrombosis and Haemostasis|April 30, 2004
The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formationGrigoris T Gerotziafas, Tahar Chakroun, François Depasse, et al.
Thrombosis Journal|October 28, 2005
Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assayGrigoris T Gerotziafas, François Depasse, Joël Busson, et al.
Thrombosis and Haemostasis|May 6, 2006
The influence of fibrin polymerization and platelet-mediated contractile forces on citrated whole blood thromboelastography profileTahar Chakroun, Grigoris T Gerotziafas, Jerhad Seghatchian, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 8, 2011
Functionality of fondaparinux (pentasaccharide) depends on clinical antithrombin levelsWalter P Jeske, Jeanine M Walenga, Meyer M Samama, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 20, 2004
Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasmaGrigoris T Gerotziafas, François Depasse, Tahar Chakroun, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2003
On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasmaGrigoris T Gerotziafas, Ismail Elalamy, François Depasse, et al.
Chest|July 24, 2008
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Jack Hirsh, Kenneth A Bauer, Maria B Donati, et al.
Pageof 3

Showing results (11-20 of 26) with videos related to

Sort By:
Pageof 3
Thrombosis Research|September 3, 2010
Comparison of a direct Factor Xa inhibitor, edoxaban, with dalteparin and ximelagatran: a randomised controlled trial in healthy elderly adultsMeyer M Samama, Satoshi Kunitada, Andŗe Oursin, et al.
Thrombosis and Haemostasis|February 26, 2004
Recombinant factor VIIa partially reverses the inhibitory effect of fondaparinux on thrombin generation after tissue factor activation in platelet rich plasma and whole bloodGrigoris T Gerotziafas, François Depasse, Tahar Chakroun, et al.
Journal of Cardiovascular Pharmacology|April 26, 2013
The effects of the antiplatelet agents, aspirin and naproxen, on pharmacokinetics and pharmacodynamics of the anticoagulant edoxaban, a direct factor Xa inhibitorJeanne Mendell, Frank Lee, Shuquan Chen, et al.
Thrombosis and Haemostasis|April 30, 2004
The role of platelets and recombinant factor VIIa on thrombin generation, platelet activation and clot formationGrigoris T Gerotziafas, Tahar Chakroun, François Depasse, et al.
Thrombosis Journal|October 28, 2005
Towards a standardization of thrombin generation assessment: the influence of tissue factor, platelets and phospholipids concentration on the normal values of Thrombogram-Thrombinoscope assayGrigoris T Gerotziafas, François Depasse, Joël Busson, et al.
Thrombosis and Haemostasis|May 6, 2006
The influence of fibrin polymerization and platelet-mediated contractile forces on citrated whole blood thromboelastography profileTahar Chakroun, Grigoris T Gerotziafas, Jerhad Seghatchian, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|February 8, 2011
Functionality of fondaparinux (pentasaccharide) depends on clinical antithrombin levelsWalter P Jeske, Jeanine M Walenga, Meyer M Samama, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|April 20, 2004
Comparison of the effect of fondaparinux and enoxaparin on thrombin generation during in-vitro clotting of whole blood and platelet-rich plasmaGrigoris T Gerotziafas, François Depasse, Tahar Chakroun, et al.
Blood Coagulation & Fibrinolysis : an International Journal in Haemostasis and Thrombosis|October 1, 2003
On the mechanism of inhibition of tissue factor pathway by the synthetic pentasaccharide during coagulation of human plasmaGrigoris T Gerotziafas, Ismail Elalamy, François Depasse, et al.
Chest|July 24, 2008
Parenteral anticoagulants: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition)Jack Hirsh, Kenneth A Bauer, Maria B Donati, et al.
Pageof 3